EP1399579A4 - Fkbp51/52 and cyp40-mediated mammalian hair growth - Google Patents

Fkbp51/52 and cyp40-mediated mammalian hair growth

Info

Publication number
EP1399579A4
EP1399579A4 EP02744577A EP02744577A EP1399579A4 EP 1399579 A4 EP1399579 A4 EP 1399579A4 EP 02744577 A EP02744577 A EP 02744577A EP 02744577 A EP02744577 A EP 02744577A EP 1399579 A4 EP1399579 A4 EP 1399579A4
Authority
EP
European Patent Office
Prior art keywords
cyp40
fkbp51
hair growth
mammalian hair
mediated mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02744577A
Other languages
German (de)
French (fr)
Other versions
EP1399579A1 (en
Inventor
Daniel Du
John Douglas Haley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anaderm Research Corp
Original Assignee
Anaderm Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anaderm Research Corp filed Critical Anaderm Research Corp
Publication of EP1399579A1 publication Critical patent/EP1399579A1/en
Publication of EP1399579A4 publication Critical patent/EP1399579A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
EP02744577A 2001-06-26 2002-06-24 Fkbp51/52 and cyp40-mediated mammalian hair growth Withdrawn EP1399579A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30087601P 2001-06-26 2001-06-26
US300876P 2001-06-26
PCT/US2002/019948 WO2003002756A1 (en) 2001-06-26 2002-06-24 Fkbp51/52 and cyp40-mediated mammalian hair growth

Publications (2)

Publication Number Publication Date
EP1399579A1 EP1399579A1 (en) 2004-03-24
EP1399579A4 true EP1399579A4 (en) 2006-04-19

Family

ID=23160965

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02744577A Withdrawn EP1399579A4 (en) 2001-06-26 2002-06-24 Fkbp51/52 and cyp40-mediated mammalian hair growth

Country Status (3)

Country Link
EP (1) EP1399579A4 (en)
JP (1) JP2005501229A (en)
WO (1) WO2003002756A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618956B2 (en) 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11174041A (en) * 1997-12-12 1999-07-02 Shiseido Co Ltd Searching method for hair growth promoting drug
WO1999038965A1 (en) * 1998-01-29 1999-08-05 The Trustees Of Columbia University In The City Of New York Human hairless gene, protein and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763590A (en) * 1991-10-11 1998-06-09 Vertex Pharmaceuticals, Inc. Isolation of an Mr 52,000 FK506 binding protein and molecular cloning of a corresponding human cDNA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11174041A (en) * 1997-12-12 1999-07-02 Shiseido Co Ltd Searching method for hair growth promoting drug
WO1999038965A1 (en) * 1998-01-29 1999-08-05 The Trustees Of Columbia University In The City Of New York Human hairless gene, protein and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BRADBURY J: "Molecular help on the horizon for hair loss?", LANCET THE, LANCET LIMITED. LONDON, GB, vol. 358, no. 9290, 20 October 2001 (2001-10-20), pages 1346, XP004805910, ISSN: 0140-6736 *
DATABASE WPI Section Ch Week 199937, Derwent World Patents Index; Class B04, AN 1999-433289, XP002369877 *
See also references of WO03002756A1 *

Also Published As

Publication number Publication date
WO2003002756A9 (en) 2004-04-15
EP1399579A1 (en) 2004-03-24
JP2005501229A (en) 2005-01-13
WO2003002756A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
EP1463742A4 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
EP1370249A4 (en) Novel dendriticpolymers and their biomedical uses
EP1426027A4 (en) Composition and cosmetic preparation containing the same
HK1068555A1 (en) New formulations and use thereof
EP1408978A4 (en) Novel phenylamino-pyrimidines and uses thereof
HRP20040077A2 (en) Crystalline forms vi and vii of atorvastatin-calcium
PT1390516E (en) Novel expression vectors and uses thereof
AU6723401A (en) Antimicrobial peptides and methods of use thereof
HU0104832D0 (en) Cosmetic composition and method
IL154553A0 (en) Urocortin-iii and uses thereof
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2002324895A8 (en) Cosmetic kit and method
HK1048724A2 (en) Hair former and hair former attachment
IL159638A0 (en) Hair lotion stimulating hair growth
IL158730A0 (en) Novel expression vectors and uses thereof
IL163926A0 (en) Crystal structure of phosphodiesterase 5 and use thereof
GB0120905D0 (en) Improving the growth of human head hair
EP1352637A4 (en) Hair growth inhibitors and compositions containing the same
EP1263935A4 (en) Scytonemin and methods of using thereof
EP1304517A4 (en) Thermostat and mounting structure of the thermostat
EP1399579A4 (en) Fkbp51/52 and cyp40-mediated mammalian hair growth
EP1449540A4 (en) Cytokine-inducing material and cytokine-inducing instrument
AU2002345832A1 (en) Fkbp51/52 and cyp40-mediated mammalian hair growth
EP1367123A4 (en) Neurotonin and use thereof
EP1392460A4 (en) Hydrogenfluorides of aminosilanols and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031203

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20060308

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/50 20060101ALI20060227BHEP

Ipc: G01N 33/68 20060101ALI20060227BHEP

Ipc: A61K 39/00 20060101ALI20060227BHEP

Ipc: C12Q 1/00 20060101AFI20030110BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20070420